Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 50, 2010, Pages 21737-21742

  Fillmore, Christine M ^a,b   Gupta, Piyush B ^c,e   Rudnick, Jenny A ^a,b   Caballero, Silvia ^a,b   Keller, Patricia J ^a,b   Lander, Eric S ^c,d   Kuperwasser, Charlotte ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 9; TAMOXIFEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBX3; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BREAST CANCER; BREAST CELL; CANCER CELL; CANCER CELL CULTURE; CARCINOGENICITY; CELL ISOLATION; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULE; PARACRINE SIGNALING; POPULATION; PRIORITY JOURNAL; STEM CELL; SURVIVAL; TUMOR SEEDING;

BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGENS; FEMALE; FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTORS; HUMANS; NEOPLASTIC STEM CELLS; PARACRINE COMMUNICATION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS;

EID: 78650732630     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1007863107     Document Type: Article

References (32)

1. Clarke MF, et al. (2006) Cancer stem cells-Perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells. Cancer Res 66:9339-9344.
2. Al-Hajj M, Wicha MS, Ito-Hernandez A (2003) Morrison SJ (2003) Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983-3988. (Pubitemid 36418143)
3. Ginestier C, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
4. Ponti D, et al. (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65:5506-5511.
5. Yu F, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131:1109-1123.
6. Fillmore CM, Kuperwasser C (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10:1-13.
7. Gupta PB, et al. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138:645-659.
8. Robinson GW (2007) Cooperation of signalling pathways in embryonic mammary gland development. Nat Rev Genet 8:963-972.
9. Rowley M, Grothey E, Couch FJ (2004) The role of Tbx2 and Tbx3 in mammary development and tumorigenesis. J Mammary Gland Biol Neoplasia 9:109-118.
10. Eblaghie MC, et al. (2004) Interactions between FGF and Wnt signals and Tbx3 gene expression in mammary gland initiation in mouse embryos. J Anat 205:1-13.
11. Dillon C, Spencer-Dene B, Dickson C (2004) A crucial role for fibroblast growth factor signaling in embryonic mammary gland development. J Mammary Gland Biol Neoplasia 9:207-215.
12. Coleman-Krnacik S, Rosen JM (1994) Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development. Mol Endocrinol 8:218-229.
13. Rosen JM, Humphreys R, Krnacik S, Juo P, Raught B (1994) The regulation of mammary gland development by hormones, growth factors, and oncogenes. Prog Clin Biol Res 387:95-111.
14. Brisken C, Duss S (2007) Stem cells and the stem cell niche in the breast: An integrated hormonal and developmental perspective. Stem Cell Rev 3:147-156.
15. Mallepell S, Krust A, Chambon P, Brisken C (2006) Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA 103:2196-2201.
16. Noel A, Simon N, Raus J, Foidart JM (1992) Basement membrane components (matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen. Biochem Pharmacol 43:1263-1267.
17. Wing LY, Chuang PC, Wu MH, Chen HM, Tsai SJ (2003) Expression and mitogenic effect of fibroblast growth factor-9 in human endometriotic implant is regulated by aberrant production of estrogen. J Clin Endocrinol Metab 88:5547-5554.
18. Rhodes DR, et al. (2004) ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 6:1-6.
19. Yarosh W, et al. (2008) TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Cancer Res 68:693-699.
20. Ben-Porath I, et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40:499-507.
21. Hassan KA, Chen G, Kalemkerian GP, Wicha MS, Beer DG (2009) An embryonic stem cell-like signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinoma. Clin Cancer Res 15:6386-6390.
22. Somervaille TC, et al. (2009) Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 4:129-140.
23. DiMeo TA, et al. (2009) A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res 69:5364-5373.
24. Asselin-Labat ML, et al. (2010) Control of mammary stem cell function by steroid hormone signalling. Nature 465:798-802.
25. Joshi PA, et al. (2010) Progesterone induces adult mammary stem cell expansion. Nature 465:803-807.
26. Horwitz KB, Dye WW, Harrell JC, Kabos P, Sartorius CA (2008) Rare steroid receptornegative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts. Proc Natl Acad Sci USA 105:5774-5779.
27. Creighton CJ, et al. (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 106: 13820-13825.
28. Cui Y, et al. (2006) Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: A mechanism of tamoxifen resistance. Cancer Res 66: 5950-5959.
29. Hiscox S, et al. (2006) Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer 118: 290-301.
30. McLeskey SW, et al. (1993) Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res 53:2168-2177.
31. Zhang L, et al. (1997) MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice. Oncogene 15:2093-2108.
32. Hajitou A, et al. (2000) Progression in MCF-7 breast cancer cell tumorigenicity: Compared effect of FGF-3 and FGF-4. Breast Cancer Res Treat 60:15-28.